A trial of NAL 6336 for respiratory disorders and allergies
Latest Information Update: 26 Aug 2016
Price :
$35 *
At a glance
- Drugs Montelukast (Primary)
- Indications Hypersensitivity; Respiratory tract disorders
- Focus Adverse reactions
- 26 Aug 2016 New trial record